Macquarie Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,000
| Closed | -$1.19M | – | 868 |
|
|
2025
Q3 | $1.19M | Sell |
25,000
-14,478
| -37% | -$701K | ﹤0.01% | 1292 |
|
|
2025
Q2 | $2.11M | Buy |
39,478
+9,478
| +32% | +$431K | ﹤0.01% | 1212 |
|
|
2025
Q1 | $1.21M | Buy |
+30,000
| New | +$1.27M | ﹤0.01% | 1355 |
|
|
2023
Q4 | – | Sell |
-22,785
| Closed | -$1.15M | – | 1640 |
|
|
2023
Q3 | $1.15M | Buy |
+22,785
| New | +$1.06M | ﹤0.01% | 1311 |
|
|
2022
Q4 | – | Sell |
-3,089
| Closed | -$119K | – | 1756 |
|
|
2022
Q3 | $119K | Sell |
3,089
-403
| -12% | -$6.17K | ﹤0.01% | 1720 |
|
|
2022
Q2 | $33K | Hold |
3,492
| – | – | ﹤0.01% | 2158 |
|
|
2022
Q1 | $50 | Hold |
3,492
| – | – | ﹤0.01% | 2137 |
|
|
2021
Q4 | $74K | Sell |
3,492
-865
| -20% | -$19.2K | ﹤0.01% | 2033 |
|
|
2021
Q3 | $97K | Buy |
+4,357
| New | +$98.6K | ﹤0.01% | 1992 |
|
